1. Home
  2. APYX vs EMBC Comparison

APYX vs EMBC Comparison

Compare APYX & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$4.12

Market Cap

196.4M

Sector

Health Care

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.37

Market Cap

207.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
EMBC
Founded
1982
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.4M
207.1M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
APYX
EMBC
Price
$4.12
$3.37
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$6.50
$18.50
AVG Volume (30 Days)
101.7K
2.4M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
19.40
20.90
EPS
N/A
0.67
Revenue
N/A
N/A
Revenue This Year
$11.93
$1.17
Revenue Next Year
$11.01
N/A
P/E Ratio
N/A
$5.13
Revenue Growth
N/A
N/A
52 Week Low
$1.59
$2.77
52 Week High
$5.08
$15.55

Technical Indicators

Market Signals
Indicator
APYX
EMBC
Relative Strength Index (RSI) 48.46 48.77
Support Level $3.85 $3.03
Resistance Level $4.29 $3.48
Average True Range (ATR) 0.27 0.14
MACD -0.03 0.06
Stochastic Oscillator 26.74 66.27

Price Performance

Historical Comparison
APYX
EMBC

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: